RenovoRx Inc.https://investorshangout.com/RenovoRx-Inc-RNXT-94712/en-usThu, 03 Sep 2026 02:31:40 GMTCopyright InvestorsHangout.comlouied91: $RNXT RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for https://investorshangout.com/post/view?id=6656141https://investorshangout.com/post/view?id=6656141Thu, 21 Dec 2023 15:03:02 GMTlouied91: $RNXT RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Ahttps://investorshangout.com/post/view?id=6655214https://investorshangout.com/post/view?id=6655214Tue, 19 Dec 2023 14:32:27 GMTLee Adams: RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual https://investorshangout.com/post/view?id=6655189https://investorshangout.com/post/view?id=6655189Tue, 19 Dec 2023 14:04:23 GMTlouied91: $RNXT RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncolohttps://investorshangout.com/post/view?id=6653142https://investorshangout.com/post/view?id=6653142Wed, 13 Dec 2023 15:31:12 GMTLee Adams: RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Thehttps://investorshangout.com/post/view?id=6653112https://investorshangout.com/post/view?id=6653112Wed, 13 Dec 2023 14:44:44 GMTLee Adams: RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D. https://investorshangout.com/post/view?id=6652787https://investorshangout.com/post/view?id=6652787Tue, 12 Dec 2023 16:49:59 GMTLee Adams: RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights Collaborahttps://investorshangout.com/post/view?id=6652784https://investorshangout.com/post/view?id=6652784Tue, 12 Dec 2023 16:47:40 GMTJ L: RNXT - Swing Cycle https://youtu.be/4lVMdKxepr0https://investorshangout.com/post/view?id=6280942https://investorshangout.com/post/view?id=6280942Wed, 10 Nov 2021 17:41:27 GMT